| SD |
systolic blood pressure |
sham surgical control condition (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
arterial blood pressure trait |
male |
days
| 6 |
undefined |
|
118.0 |
mmHg |
4.08 |
10.0 |
tail cuff plethysmography |
0.0 |
sham unx |
28 |
days |
101583 |
2602 |
| WF/Mol |
systolic blood pressure |
vehicle control condition then sham surgical control condition (for 2 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
arterial blood pressure trait |
male |
days
| 6 |
undefined |
|
150.0 |
mmHg |
4.0 |
9.8 |
tail cuff plethysmography |
0.0 |
sham acf |
2 |
days |
101357 |
2585 |
| WF/Mol |
systolic blood pressure |
controlled ramipril content drinking water (3 mg/kg/d) (for 5 days) then sham surgical control condition (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
arterial blood pressure trait |
male |
days
| 5 |
undefined |
|
106.0 |
mmHg |
4.0 |
8.94 |
tail cuff plethysmography |
0.0 |
sham acf |
4 |
days |
101345 |
2585 |
| SD |
systolic blood pressure |
sham surgical control condition (for 140 days) |
Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. |
arterial blood pressure trait |
male |
189.0 days
| 6 |
undefined |
|
144.0 |
mmHg |
2.0 |
4.9 |
tail cuff plethysmography |
0.0 |
sham lad occlusion |
140 |
days |
101090 |
2564 |
| WF/Mol |
systolic blood pressure |
vehicle control condition then sham surgical control condition (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
arterial blood pressure trait |
male |
days
| 5 |
undefined |
|
130.0 |
mmHg |
2.0 |
4.47 |
tail cuff plethysmography |
0.0 |
sham acf |
7 |
days |
101351 |
2585 |
| WF/Mol |
systolic blood pressure |
vehicle control condition then sham surgical control condition (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
arterial blood pressure trait |
male |
days
| 5 |
undefined |
|
160.0 |
mmHg |
4.0 |
8.94 |
tail cuff plethysmography |
0.0 |
sham acf |
4 |
days |
101361 |
2585 |
| WF/Mol |
systolic blood pressure |
controlled losartan content drinking water (10 mg/kg/d) (for 5 days) then sham surgical control condition (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
arterial blood pressure trait |
male |
days
| 6 |
undefined |
|
143.0 |
mmHg |
5.0 |
12.25 |
tail cuff plethysmography |
0.0 |
sham acf |
4 |
days |
101359 |
2585 |
| WF/Mol |
systolic blood pressure |
controlled losartan content drinking water (10 mg/kg/d) (for 8 days) then sham surgical control condition (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
arterial blood pressure trait |
male |
days
| 6 |
undefined |
|
130.0 |
mmHg |
3.0 |
7.35 |
tail cuff plethysmography |
0.0 |
sham acf |
7 |
days |
101363 |
2585 |
| WF/Mol |
systolic blood pressure |
controlled ramipril content drinking water (3 mg/kg/d) (for 8 days) then sham surgical control condition (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
arterial blood pressure trait |
male |
days
| 5 |
undefined |
|
129.0 |
mmHg |
6.0 |
13.42 |
tail cuff plethysmography |
0.0 |
sham acf |
7 |
days |
101349 |
2585 |
| WF/Mol |
systolic blood pressure |
vehicle control condition then sham surgical control condition (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
arterial blood pressure trait |
male |
days
| 5 |
undefined |
|
165.0 |
mmHg |
7.0 |
15.65 |
tail cuff plethysmography |
0.0 |
sham acf |
7 |
days |
101365 |
2585 |
| SD |
systolic blood pressure |
sham surgical control condition (for 28 days) |
Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. |
arterial blood pressure trait |
male |
77.0 days
| 6 |
undefined |
|
134.0 |
mmHg |
2.0 |
4.9 |
tail cuff plethysmography |
0.0 |
sham lad occlusion |
28 |
days |
101088 |
2564 |
| WKY |
systolic blood pressure |
sham surgical control condition (for 224 days) then ketamine (80 mg/kg) then xylazine (10 mg/kg) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
arterial blood pressure trait |
male |
266.0 days-280.0 days |
5 |
10 min mean |
continuous mean |
97.8 |
mmHg |
6.3 |
14.09 |
vascular transducer tipped catheter |
0.0 |
lad occlusion sham |
210 |
days |
100315 |
2460 |
| SD |
systolic blood pressure |
sham surgical control condition (between 12 and 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
arterial blood pressure trait |
male |
days
| 6 |
undefined |
|
118.0 |
mmHg |
3.67 |
9.0 |
tail cuff plethysmography |
0.0 |
sham unx |
13 |
days |
101547 |
2602 |
| WF/Mol |
systolic blood pressure |
vehicle control condition then sham surgical control condition (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
arterial blood pressure trait |
male |
days
| 5 |
undefined |
|
123.0 |
mmHg |
5.0 |
11.18 |
tail cuff plethysmography |
0.0 |
sham acf |
4 |
days |
101347 |
2585 |
| WF/Mol |
systolic blood pressure |
controlled losartan content drinking water (10 mg/kg/d) (for 3 days) then sham surgical control condition (for 2 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
arterial blood pressure trait |
male |
days
| 5 |
undefined |
|
151.0 |
mmHg |
5.0 |
11.18 |
tail cuff plethysmography |
0.0 |
sham acf |
2 |
days |
101355 |
2585 |